The Minneapolis Heart Institute Foundation (MHIF) and Allina Health Minneapolis Heart Institute (AHMHI) are making a major splash at this year's American College of Cardiology (ACC) Annual Scientific Session in New Orleans, presenting decades of cardiovascular research that could reshape how doctors diagnose and treat heart disease. From March 28 to 30, 2026, faculty, trainees, and research staff from Minnesota will participate in 45 scientific sessions, representing nearly every major area of cardiovascular medicine .

What Are the Biggest Research Highlights from This Conference?

The Minnesota team is bringing substantial firepower to the national stage. The institute has 30 accepted abstracts, including 9 moderated poster presentations that will be reviewed by leading cardiologists. Most notably, three late-breaking clinical trials led or co-led by AHMHI and MHIF investigators will be presented, offering fresh insights into cutting-edge treatments and diagnostic approaches .

One standout presentation is the ORBITA-CTO trial, a randomized, placebo-controlled study examining chronic total occlusion percutaneous coronary intervention in patients with stable angina. This research, presented in collaboration with the New England Journal of Medicine, represents the kind of rigorous, peer-reviewed clinical trial that can shift treatment guidelines nationwide .

Beyond the headline trials, the research spans critical areas including:

• Sex-Based Differences in Heart Disease: Multiple studies examine how coronary artery disease, myocardial infarction, and cardiovascular risk factors present differently in men and women, using advanced imaging like cardiac magnetic resonance imaging and AI-powered coronary CT analysis
• Heart Failure Management: Research on diuretic dosing in acute decompensated heart failure and the role of beta-blockers in patients with higher ejection fractions
• Advanced Imaging Technology: Studies on photon-counting CT for procedural planning, liver extracellular volume as a prognostic marker, and how coronary CT angiography (CCTA) is reshaping percutaneous coronary intervention (PCI) planning
• Vascular Disease: Research on complex aortic aneurysm repair and rare vascular conditions
• Health Equity: Investigation of income-based disparities in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among U.S. adults

How Is the Next Generation of Cardiologists Contributing to This Research?

A significant portion of the conference presence comes from trainees and early-career researchers. The institute will showcase 24 trainee-led scientific presentations, including 9 intern presentations, 11 scholar presentations, and 4 resident and fellow presentations . This commitment to developing future leaders in cardiovascular medicine reflects a broader mission to sustain innovation in heart disease research for decades to come.

The Minnesota cardiovascular fellows team will also compete in the Fellows-in-Training (FIT) Jeopardy Competition, facing teams from Kentucky, Ohio, and Massachusetts. This friendly competition highlights the collaborative spirit of medical education while celebrating the expertise of emerging cardiologists .

Steps to Stay Informed About Cardiovascular Research Advances

• Follow Major Medical Conferences: The ACC Annual Scientific Session is one of the largest gatherings of cardiologists in the world. Major presentations often signal shifts in clinical practice, so tracking conference announcements can help you understand emerging treatments before they become standard care
• Look for Peer-Reviewed Publication: Abstracts presented at conferences are typically published in peer-reviewed journals within 6 to 12 months. Search PubMed or your institution's library for the full study once it's published to get complete data and methodology
• Discuss New Findings with Your Doctor: If you have heart disease or cardiovascular risk factors, ask your cardiologist about emerging treatments or diagnostic approaches presented at major conferences. Your doctor can explain how new research applies to your specific situation

The breadth of research being presented underscores the complexity of cardiovascular disease and the need for continued innovation. From understanding why women and men experience heart attacks differently to developing new imaging technologies that help doctors plan procedures more precisely, these studies address real gaps in clinical knowledge .

One particularly noteworthy area is the focus on health disparities. Research on income-based differences in access to GLP-1 receptor agonists, medications that have shown cardiovascular benefits beyond blood sugar control, highlights how socioeconomic factors influence treatment availability. This kind of research is essential for addressing inequities in cardiovascular care .

The institute also celebrates the recognition of Dr. Oksana Marchenko, a MHIF Core Lab analyst, who will be inducted as a Fellow of the American College of Cardiology (FACC) during the meeting. This honor recognizes her contributions to cardiovascular imaging and research, underscoring the importance of specialized expertise in advancing the field .

For patients and the general public, the takeaway is clear: cardiovascular research is evolving rapidly, with new insights into prevention, diagnosis, and treatment emerging constantly. The work being presented in New Orleans this weekend represents years of careful study and collaboration, and many of these findings will eventually influence how your doctor approaches your heart health. Staying informed about these advances and discussing them with your healthcare provider can help you make better decisions about your cardiovascular care.